Insight Tribune

Pfizer Sees 2025 Revenue in Line With Wall Street Views

Pfizer Sees 2025 Revenue in Line With Wall Street Views




Pfizer forecast 2025 revenue and earnings in line with market expectations, despite a $1 billion hit from the redesign of federal drug benefits.

Exit mobile version